FDA — authorised 23 March 1943
- Marketing authorisation holder: ENDO PHARMS
- Status: approved
FDA authorised Hycodan on 23 March 1943
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 March 1943; FDA authorised it on 23 March 1943.
ENDO PHARMS holds the US marketing authorisation.